Our investments

We focus on innovation, governance, and long-term value creation.

We work with institutional and individual investment partners and have a formal co-investment agreement with Excalibur Healthcare Services Ltd.

Fixit Medical

ETHTRY has a 20% equity stake in Fixit Medical Ltd

20%
Find out more

Fixit Medical is dedicated to advancing healthcare by developing innovative medical devices that prioritise patient safety, comfort, and ease of use. With a focus on improving healthcare outcomes, Fixit Medical addresses key challenges in the field, delivering effective solutions that enhance patient care and improve overall experiences.

Our range of products is designed with healthcare professionals and patients in mind, ensuring high-quality performance and reliability in clinical settings.

Fixit Medical has recently launched three additional innovative devices alongside its principal product, Cingo®. These new projects, which have been planned for some time named “Project CO2,” “PI01,” and “PI03,” are complementary devices targeting distinct markets. Fixit Medical has filed patents for all three projects and will share further details in the coming months. This expansion enhances the valuation of Fixit Medical’s intellectual property (IP) and builds a cohesive “family of devices”

GEM Energia Limited

Igraine holds the exclusive investment rights over GEM Energia Limited and its Special Purpose Vehicles, including a right of first refusal on all current and future battery storage projects with GEM’s portfolio.

Find out more

GEM was established by David Levis, distinguished and specialised in the development of battery energy storage systems across the UK. Operating through wholly-owned subsidiaries, GEM is dedicated to increasing the number of battery storage sites across the country aimed at stabilising the national grid and supporting the integration of renewable energy sources.

As the UK continues its transition to greener energy solutions, battery storage facilities play a critical role in addressing the increasing demand for energy storage. These systems enable excess electricity, often generated by renewable sources such as solar and wind, to be stored and deployed during periods of high demand, thus ensuring the efficient utilisation of renewable resources and enhancing grid stability.

GEM identifies and secures the rights over development sites for battery energy storage facilities, which are then required to go through a full planning process. Initially obtained through an option agreement and a letter of authority from the landowner, these sites are converted into long-term lucrative leases for the landowner once the site is built out.

GEM commercial rational:
  1. Costs to achieve suitable planning consent and obtain grid connection ranges from circa £120,000 for a 30MW site up to circa £550,000 for a 400MW site, depending on the capacity size of the land. The timing is typically over a 12-to-24-month period.
  2. At RTB, the expected sale value that a typical 100MW site can achieve is between £6 – £12 million post granting of planning permission, compared to a cost outlay of approximately £200,000.
  3. GEM currently has 6 sites that with available funding are ready to progress to planning application stages and RTB.

Other investments

Igraine has invested in Excalibur Medicines Ltd (“EML”), a subsidiary of Excalibur Healthcare Services Ltd. EML has secured exclusive rights to and owns the COVID-19 patents on a drug, AZD1656, which is being developed as a potential therapeutic for diabetics suffering from COVID-19.

Strategic pillars

“Our strategy fuses the certainty of infrastructure with the innovation of digital finance.”

Energy Storage & Infrastructure

Data Centres & Digital Power

  • Bitcoin $67,420.55 2.16%
  • Ethereum $3,215.89 2.16%
  • Dash $42.77 5.63%
  • XRP $2.407 3.22%

Ethereum Treasury

Capital Discipline

Create your account